Cancer testis antigen and immunotherapy

被引：45
|
作者：
Krishnadas, Deepa Kolaseri [1 ]
Bai, Fanqi [1 ]
Lucas, Kenneth G. [1 ]
机构：
[1] Univ Louisville, Dept Pediat, Div Hematol Oncol, Louisville, KY 40292 USA
来源：
IMMUNOTARGETS AND THERAPY | 2013年 / 2卷
关键词：
cancer testis antigens; immunotherapy; vaccine;
D O I：
10.2147/ITT.S35570
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The identification of cancer testis (CT) antigens has been an important advance in determining potential targets for cancer immunotherapy. Multiple previous studies have shown that CT antigen vaccines, using both peptides and dendritic cell vaccines, can elicit clinical and immunologic responses in several different tumors. This review details the expression of melanoma antigen family A, 1 (MAGE-A1), melanoma antigen family A, 3 (MAGE-A3), and New York esophageal squamous cell carcinoma-1 (NY-ESO-1) in various malignancies, and presents our current understanding of CT antigen based immunotherapy.
引用
收藏
页码：11 / 19
页数：9
相关论文
共 50 条
  • [31] Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma
    Sara Yousef
    Johanna Heise
    Nesrine Lajmi
    Katrin Bartels
    Nicolaus Kröger
    Tim Luetkens
    Djordje Atanackovic
    Journal of Translational Medicine, 13
  • [32] CANCER-TESTIS ANTIGEN SLLP1 REPRESENTS A PROMISING TARGET FOR THE IMMUNOTHERAPY OF MULTIPLE MYELOMA
    Yousef, S.
    Heise, J.
    Lajmi, N.
    Luetkens, T.
    Kroeger, N.
    Atanackovic, D.
    HAEMATOLOGICA, 2015, 100 : 741 - 741
  • [33] TARP as antigen in cancer immunotherapy
    Jolien Vanhooren
    Charlotte Derpoorter
    Barbara Depreter
    Larissa Deneweth
    Jan Philippé
    Barbara De Moerloose
    Tim Lammens
    Cancer Immunology, Immunotherapy, 2021, 70 : 3061 - 3068
  • [34] TARP as antigen in cancer immunotherapy
    Vanhooren, Jolien
    Derpoorter, Charlotte
    Depreter, Barbara
    Deneweth, Larissa
    Philippe, Jan
    De Moerloose, Barbara
    Lammens, Tim
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (11) : 3061 - 3068
  • [35] Targeting SSX cancer–testis antigens for immunotherapy
    Annette Fenner
    Nature Reviews Urology, 2011, 8 (12) : 647 - 647
  • [36] Overexpression of cancer-testis antigen melanoma-associated antigen A1 in lung cancer: A novel biomarker for prognosis, and a possible target for immunotherapy
    Fanipakdel, Azar
    Toussi, Mehdi Seilanian
    Rezazadeh, Faezeh
    Roshan, Nema Mohamadian
    Javadinia, Seyed Alireza
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) : 12080 - 12086
  • [37] Inhibition of Histone Lysine Methylation Enhances Cancer-Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer
    Rao, Mahadev
    Chinnasamy, Nachimuthu
    Hong, Julie A.
    Zhang, Yuwei
    Zhang, Mary
    Xi, Sichuan
    Liu, Fang
    Marquez, Victor E.
    Morgan, Richard A.
    Schrump, David S.
    CANCER RESEARCH, 2011, 71 (12) : 4192 - 4204
  • [38] Cause and Consequence of Cancer/Testis Antigen Activation in Cancer
    Whitehurst, Angelique W.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54, 2014, 54 : 251 - 272
  • [39] Cancer-testis antigen expression in bladder cancer
    Fradet, Yves
    Picard, V.
    Bergeron, A.
    LaRue, H.
    PROGRES EN UROLOGIE, 2005, 15 (06): : 1303 - 1313
  • [40] Cancer-testis antigen expression in bladder cancer
    Fradet, Yves
    Picard, Valere
    Bergeron, Alain
    LaRue, Helene
    PROGRES EN UROLOGIE, 2006, 16 (04): : 421 - 428
12345